Like other inhaled prostaglandins, YUTREPIA may cause acute bronchospasm. Patients with asthma or chronic obstructive pulmonary disease (COPD), or other bronchial hyperreactivity, are at increased ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately ...

Patients with persistent fish allergy and parvalbumin sensitization had a low threshold for reactions, which were severe, ...

Ionis Pharmaceuticals, Inc. today announced positive topline results from the Essence study of olezarsen in people with moderate hypertriglyceridemia (fasting triglycerides ?150 mg/dL to <500 mg/dL) ...

If you're struggling with a chronic cough, it may be linked to several illnesses that are on the rise, according to public health providers.

Smoking cannabis could trigger bronchospasm or worsen symptoms of the condition you’re using Xopenex HFA to treat. As with any drug or supplement, talk with your doctor before using cannabis ...

Arterial oxygen and carbon dioxide tensions, pH and forced expiratory volumes were measured in 101 asthmatic patients during acute attacks of bronchospasm ... or in whom symptoms had developed ...

Learn why popcorn poses serious choking hazards to children under 3. Discover the anatomical vulnerabilities, emergency challenges, and safer alternatives ...

Yutrepia is an inhaled dry powder formulation of treprostinil approved in the U.S. to improve exercise capacity in PAH and PH ...

Neurological symptoms such as dizziness, slurred speech, a splitting headache, numbness, and others may indicate a health ...

Recognizing early warning signs, known as prodromal symptoms, is crucial. Symptoms like chest discomfort, breathlessness, unusual fatigue, cold sweats, nausea, and dizziness can manifest weeks or ...

It’s nerve-wracking to hear that a new variant is making the rounds, but infectious disease specialists say there are no ...